Parexel, Parexel Announce Multi-year Strategic Partnership To Leverage AI To Help Enhance And Accelerate Delivery Of Safe And Effective Clinical Trials
Parexel, Parexel Announce Multi-year Strategic Partnership To Leverage AI To Help Enhance And Accelerate Delivery Of Safe And Effective Clinical Trials
Parexel 和 Parexel 宣佈建立多年戰略合作伙伴關係，利用人工智能幫助增強和加快安全有效的臨床試驗的交付
Under the collaboration, Parexel will leverage Palantir's Foundry and Artificial Intelligence Platform (AIP) to further power its clinical data platform, focused on driving clinical trial efficiency while maintaining the highest level of safety and regulatory rigor. Parexel is the first CRO working with Palantir in this capacity, building on the companies' existing collaboration over the past year.
根據合作，Parexel將利用Palantir的鑄造和人工智能平台（AIP）進一步推動其臨床數據平台的發展，該平台側重於提高臨床試驗效率，同時保持最高水平的安全性和監管嚴格。Parexel是第一家以此身份與Palantir合作的CRO，這是兩家公司在過去一年中現有合作的基礎上。